发展中国家乙型肝炎流行、预防和控制

许晶瑶; 谢韬; 姚文清

doi:10.11847/zgggws2016-32-01-10

发展中国家乙型肝炎流行、预防和控制

doi: 10.11847/zgggws2016-32-01-10

辽宁省疾病预防控制中心业务与应急管理办公室, 沈阳 110005

详细信息

作者简介:
许晶瑶(1964-),女,辽宁大连人,副主任医师,硕士,主要从事卫生应急管理工作。

中图分类号: R
计量
- 文章访问数: 783
- HTML全文浏览量: 219
- PDF下载量: 82
- 被引次数: 0
出版历程
- 收稿日期: 2014-07-29
- 刊出日期: 2016-01-10

Prevalence,prevention and control of hepatitis B in developing countries

Public Health Service and Emergency Management Office, Liaoning Provincial Center for Disease Control and Prevention, Shenyang, Liaoning Province 110005, China

摘要

摘要: 乙型肝炎病毒(HBV)感染是严重的全球公共卫生问题。根据乙肝病毒携带率,全世界分为高、中、低流行3个区,在高流行区,最常见的感染途径仍然是从母亲到小孩的垂直传播。感染率能够通过改变行为、提高个人教育、检查全部献血员、确保临床操作无菌和筛查全部孕妇得到降低。接种安全有效的乙型肝炎疫苗是预防乙型肝炎的主要方法,持久的病毒性肝炎治疗计划也是降低乙肝相关疾病负担的必需措施。
- 乙型肝炎 /
- 发展中国家 /
- 流行 /
- 疫苗 /
- 预防和控制
Abstract: Hepatitis B virus(HBV)infection is a serious global public health problem and based on the prevalence rate of HBV infection,the world can be divided into high-,medium-,and low-epidemic regions.In countries with high prevalence of HBV infection,the most common route of infection is vertical transmission from mother to child.The HBV infection rate could be reduced by modifying relevant behaviors,promoting individual health education,detecting all blood donations,assuring asepsis in clinical practice,and screening on HBV infection indicators among all pregnant women.However,adoption of a safe and efficacious hepatitis B vaccine is the main way to prevent hepatitis B.A long-term viral hepatitis treatment program is still necessary to reduce the burden of hepatitis B-related disease.
- hepatitis B /
- developing country /
- prevalence /
- vaccine /
- prevention and control

HTML全文

参考文献(21)

[1]	世界卫生组织.病毒性肝炎感染的预防与控制:全球行动框架[EB/OL].Http://www.who.int/topics/hepatitis/zh/健康主题/肝炎.
[2]	世界卫生组织.乙型肝炎[EB/OL].Http://www.who.int/topics/hepatitis/zh/媒体中心/实况报道,第204号.
[3]	世界卫生组织.乙型肝炎免疫接种纳入儿童常规免疫服务[EB/OL].Http://www.who.int/publications/list/who_vb_01_31/zh/.
[4]	Zanetti AR,Van Damme P,Shouval D.The global impact of vaccination against hepatitis B:a historical overview[J].Vaccine,2008,26(49):6266-73.
[5]	Shrestha P,Bhandari D,Sharma D,et al.A study of viral hepatitis during pregnancy in Nepal Medical College Teaching Hospital[J].Nepal Med Coll J,2009,11(3):192-194.
[6]	El-Magrahe H,Furarah AR,El-Figih K,et al.Maternal and neonatal seroprevalence of hepatitis B surface antigen(HBsAg)in Tripoli,Libya[J].J Infect Dev Ctries,2010,4(3):168-170.
[7]	Zhang S,Li RT,Wang Y,et al.Seroprevalence of hepatitis B surface antigen among pregnant women in Jiangsu,China,17 years after introduction of hepatitis B vaccine[J].Int J Gynaecol Obstet,2010,109(3):194-197.
[8]	Yuen MF,Lee CK,Wong DK,et al.Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B:a study of a large blood donor population[J].Gut,2010,59(10):1389-1393.
[9]	Acar A,Kemahli S,Altunay H,et al.HBV,HCV and HIV seroprevalence among blood donors in Istanbul,Turkey:how effective are the changes in the national blood transfusion policies?[J].Braz J Infect Dis,2010,14(1):41-46.
[10]	WHO.Blood transfusion safety[EB/OL].Http://www.who.int/bloodsafety/en/Blood-Transfusion-Safety/.
[11]	Tiwari BR,Ghimire P,Kandel SR,et al.Seroprevalence of HBV and HCV in blood donors:a study from regional blood transfusion services of Nepal[J].Asian J Transfus Sci,2010,4(2):91-93.
[12]	McClune AC,Tong MJ.Chronic hepatitis B and hepatocellular carcinoma[J].Clin Liver Dis,2010,14(3):461-476.
[13]	Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.Prevention of hepatocellular carcinoma in the Asia-Pacific region:consensus statements[J].J Gastroenterol Hepatol,2010,25(4):657-663.
[14]	Elisabetta F,Barbara B,Maria GM,et al.Hepatitis B:epidemiology and prevention in developing countries[J].World J Hepatol,2012,4(3):74-80.
[15]	陈华,张菊英,何芳,等.绵阳市1-15岁儿童乙肝疫苗免疫效果调查[J].中国公共卫生,2014,30(7):884-886.
[16]	Chen DS.Toward elimination and eradication of hepatitis B[J].J Gastroenterol Hepatol,2010,25(1):19-25.
[17]	世界卫生组织.中国乙肝疫苗接种常见问题[EB/OL].Http://www.wpro.who.int/china/mediacentre/releases/2014/20140818/zh/.
[18]	世界卫生组织.及时接种乙肝疫苗出生剂次是获得终生保护的关键[EB/OL].Http://www.wpro.who.int/china/mediacentre/releases/2014/20140424/zh/.
[19]	Monica CR.Hepatitis B prevention and control:lessons from the East and the West[J].World J Hepatol,2011,3(2):31-37.
[20]	王平贵,高丽,安婧袁,等.甘肃省新生儿乙肝疫苗首针及时接种率试点项目评价[J].中国公共卫生,2013,29(8):1199-1202.
[21]	刘彩.农村儿童乙肝疫苗首针及时接种现状及影响因素[J].中国公共卫生,2014,30(12):1496-1499.